Compass Biotechnologies, Inc. to Change Name to Motion Entertainment Group, Inc.

Company has Applied for Name Change and Trading Symbol Change

SALT LAKE CITY, UT / ACCESSWIRE / July 25, 2016 / Compass Biotechnologies Inc. COBI, a cutting edge audio and entertainment company, has officially changed the corporate name to Motion Entertainment Group Inc. The name change better embodies the vision and business model of the company. Now that the name change is effective, the company has applied to FINRA for a new trading symbol reflecting this change.

"This is only the first of many steps and upcoming milestones to propel our company onto the global entertainment stage. The name and trading symbol change is a perfect fit for our vision and model. After months of careful consideration, the recapitalization of the company was necessary to take advantage of pending and potential strategic opportunities, ensuring us ample ability to further grow the company and deliver value to our shareholders. Now we can truly get started on building the business and showing progress to our shareholders," said President Smith. "As the sole executive officer of the company, I am actively searching for an extensive and experienced team of executives to take our company to the next level and beyond. As well, I will strive to keep shareholders informed on the progress of our young but promising company."

Safe Harbor Statement:

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934 that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations and assumptions upon which they are based are reasonable, we can give no assurance that such expectations and assumptions will prove to have been correct. Some of these uncertainties include, without limitation, the company's ability to perform under existing contracts or to procure future contracts. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including without limitation, successful implementation of our business strategy and competition, any of which may cause actual results to differ materially from those described in the statements. We undertake no obligation and do not intend to update, revise or otherwise publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of any unanticipated events. Although we believe that our expectations are based on reasonable assumptions, we can give no assurance that our expectations will materialize. Many factors could cause actual results to differ materially from our forward-looking statements.

Contact:

Investor Relations
info@compasscobi.com

https://twitter.com/compasscobi

SOURCE: Compass Biotechnologies Inc.